RESEARCH ARTICLE


https://doi.org/10.5005/jp-journals-10005-1998
International Journal of Clinical Pediatric Dentistry
Volume 14 | Issue 4 | Year 2021

Comparative Evaluation of the Effectiveness of Different Pain-alleviating Methods before Local Anesthetic Administration in Children of 6 to 12 Years of Age: A Clinical Study


Sudha B Patil1, Divya D Popali2, Prashant A Bondarde3, Nikhil S Khandare4, Akshay R Kothari5, Pooja S Chawla6, Sayali Gawale7, Gaurav A Shinde8, Rachana S Agrawal9, Aditi S Patkar10, Saurabh R Mirgal11

1–11Department of Pedodontics, JMF’s ACPM Dental College, Dhule, Maharashtra, India

Corresponding Author: Divya D Popali, Department of Pedodontics, JMF’s ACPM Dental College, Dhule, Maharashtra, India, Phone: +91 9850182888, e-mail: dpopali05@gmail.com

How to cite this article Patil SB, Popali DD, Bondarde PA, et al. Comparative Evaluation of the Effectiveness of Different Pain-alleviating Methods before Local Anesthetic Administration in Children of 6 to 12 Years of Age: A Clinical Study. Int J Clin Pediatr Dent 2021;14(4):447–453.

Source of support: Nil

Conflict of interest: None

ABSTRACT

Background and aim of the study: Pediatric patients are apprehensive regarding having dental treatment mainly because of painful local anesthetic (LA) injections. Various techniques like transcutaneous electrical nerve stimulation (TENS), topical anesthetic agents, and vibrator device are introduced to reduce discomfort before LA administration. Therefore, the present study aimed to compare and evaluate the effectiveness of TENS, 2% lignocaine gel, eutectic mixture of lignocaine and prilocaine (EMLA), and vibrating device before LA injections in alleviating pain in pediatric patients.

Materials and methods: Sixty healthy children aged 6 to 12 years who required LA injections for dental procedures were selected and divided into four groups with 15 patients in each group. Wong–Baker’s facial pain rating scale (WBFPRS) and face, legs, activity, cry, and consolability scale (FLACC) are used for pain perception which are tabulated, and statistically analyzed.

Results: The test results demonstrated that the TENS group has shown the least mean WBFPRS and FLACC score, followed by vibrator devices, EMLA gel, and lignocaine gel.

Conclusion: The newly introduced TENS apparatus showed encouraging results, hence can be used as a safe and reliable technique to be used in pediatric dentistry.

Keywords: 2% Lignocaine, Eutectic mixture of lignocaine and prilocaine, Pain scales, Transcutaneous electrical nerve stimulation, Vibrator.

INTRODUCTION

The main concern of the pediatric dentist is to achieve the cooperation of the child in the dental clinic during various pediatric procedures. Administering anesthesia to pediatric patients proves to be the most challenging part of the process. The real fear of the child during a pediatric procedure is painful local anesthetic (LA) injections. The mere sight of needle and syringes cause psychological trauma to the child and thus interferes with the behavior management of a child. Reducing the fear of pain during LA injections gains the confidence of the child toward the dentist, thus achieving the cooperation of the child during treatment.

Various techniques are available to reduce discomfort during LA injections. Transcutaneous electrical nerve stimulation (TENS) works on the principle of gate control theory given by Melzack and Wall in 1965. Shane and Kessler in 1967 first described its use in various fields related to medicines.1 Transcutaneous electrical nerve stimulation directly stimulates the nerves by electrical impulses of short duration and small amplitude for pain reduction during LA injections.2 Transcutaneous electrical nerve stimulation proved to be more comfortable and beneficial in reducing pain and anxiety during LA injections.

Topical anesthetic agents are commonly used before the administration of LA injections. Nakanishi et al. found that the site of injection plays an essential role in the efficacy of topical anesthetic agents. 2% lignocaine gel produces surface anesthesia; however, it has a limited capacity of penetrating deep into tissues.2 A cutaneous topical anesthetic which was first used in dermatology in the 1980s, eutectic mixture of lignocaine and prilocaine (EMLA) – “a 1:1 mixture of 2.5% prilocaine and 2.5% lidocaine”. The first trial to administer EMLA cream in the mucosal surface was first described by Holst and Evers.3

The vibration device is also a technique in reducing pain during LA administration, and it works on the principle of gate control theory of pain. Inhibitory interneurons in the spinal cord get stimulated by touch and vibratory stimuli which restricts the information carried by A-δ and C fibers to second-order neurons of the spinal cord.4 Thus, pain stimuli get eliminated. Hence, this study was aimed to compare and evaluate the effect of various pain alleviating techniques such as the application of a topical anesthetic gel, TENS, and vibration device in reducing pain among pediatric patients requiring anesthesia during routine dental procedures.

MATERIALS AND METHODS

Materials

The apparatus used was the TENS apparatus with two electrode rods, 2% lignocaine gel, EMLA gel, and a vibrator device. Diagnostic instruments, LA syringe, and povidone–iodine solution (Fig. 1).

Wong–Baker’s facial pain scale and FLACC scale were used for pain perception.

Methods

Written consent was obtained from parents explaining the procedure to them in the local language before beginning with the process.

Sample

6 to 12 years of children visiting the Department of Pedodontics and Preventive Dentistry, ACPM Dental College, Dhule, requiring the need for local anesthesia were considered for the study.

Sample Size

A total of 60 subjects requiring the need for LA injections were selected randomly for the study upon fulfilling the following criteria.

Inclusion Criteria

  • Children who are never exposed to TENS, EMLA jelly, lignocaine jelly, and vibrator device.
  • Children who require LA injections and in whom parental consent was obtained.

Exclusion Criteria

  • Children with epileptic disorder.
  • Children with a history of cardiac and bleeding disorder.
  • Immature children who cannot understand the concept of pain.
  • Physically and mentally challenged children.
  • Children with unknown skin allergies.

Study Design

Sixty children were randomly divided into four groups with 15 children in each group requiring the need for local anesthesia before the procedure.

Group I: Children received TENS stimuli.

Group II: Children received 2% lignocaine gel.

Group III: Children received EMLA gel.

Group IV: Children received vibration stimuli.

Group I (TENS Group)

Transcutaneous electrical nerve stimulation unit comprises a control unit and electrode pads (Fig. 2). The electrode pads can be applied extraorally, which was a cumbersome method, time-consuming, and patient cooperation was required. Thus, it was modified using electrode rods, which can be applied intraorally (Fig. 3).

The site of needle insertion was gently swabbed with povidone–iodine. Electrode rods are wrapped with cotton and moistened with water. Transcutaneous electrical nerve stimulation electrodes rods are placed intraorally on the mucous membrane over the site of needle insertion. The amplitude and frequency of the TENS unit were adjusted until the child felt a warm, twitching sensation. The LA solution was then deposited, and a TENS stimulation was maintained until the deposition of the solution into the tissue (Fig. 4).

Group II (Lignocaine Group)

At the injection site, 2% lignocaine gel was applied for 2 minutes, and then the LA solution was deposited (Fig. 5).

Group III (EMLA Group)

Eutectic mixture of lignocaine and prilocaine gel was applied at the injection site for 3 to 5 minutes, and the LA solution was then deposited (Fig. 6).

Group IV (Vibrator Group)

A vibrating device was placed extraorally on the same side to the site of injection. The device was placed along the inferior border of the mandibular ramus for mandibular injections. The device was set against the zygomatic arch for maxillary injections. Amplitude was gradually increased from 0 to 2 modes until the patient feels the twitching sensation. Local anesthetic solution was deposited until vibration mode was maintained until the deposition of the solution into tissues (Fig. 7).

2% lignocaine with 1:80,000 adrenaline is used in each group. Pain assessment was done using Wong–Baker’s Facial Pain Scale (Fig. 8) and face, legs, activity, cry, and consolability scale (FLACC) (Table 1) after administration of LA solution in all the four groups.

Fig. 1: Armamentarium used

OBSERVATION

Wong–Baker’s facial pain scale

In this, the rate of discomfort was asked from child on a 0 to 10 score with a smiling child at one end and a tearful child at the other. The distance along the scale from the smiling child was taken as the pain score (Fig. 9).

FLACC Scale

In this scale, the operator observes the level of discomfort from 0 to 2 in each of the 5 categories, and the scale was scored in a range of 0 to 10.

Fig. 2: TENS apparatus with extraoral electrode pads

Fig. 3: Modification of TENS electrode

Figs 4A and B: Application of TENS electrodes in group I

Figs 5A and B: 2% lignocaine jelly application in group II

RESULTS

The values were subjected to the statistical analysis in which the ANOVA test was performed. Most significant pain reduction was observed in the TENS group with Wong–Baker faces mean pain score of 2.4 followed by vibration group with a mean pain score of 3.2, then EMLA group with a mean score of 4.13, and lastly 2% lignocaine jelly with 6.4 mean scores (Fig. 10 and Table 2).

Similarly, minimum pain felt in the TENS group with FLACC scale mean pain score of 1.47 followed by vibration group with a mean pain score of 1.80 then EMLA group with a mean score of 2.27, and lastly 2% lignocaine jelly with a mean score of 5.4 (Fig. 11 and Table 3).

The result obtained was statistically significant with p = <0.05, suggesting the TENS application to be more effective in reducing pain sensation.

DISCUSSION

Pain is the most undesirable aspect of pediatric dentistry, which can lead to significant uncooperative behavior of the child in the dental office. By reducing the pain associated with LA administration, the patient can get maximum comfort and satisfaction. The primary aim of all clinicians is to give painless LA. Continuous research has been carried out for newer methodologies and techniques which can make dental treatment under LA more comfortable.2

To decrease the pain and discomfort caused by injections, various alternatives are available such as topical anesthetic application or application of TENS and vibration stimuli.

In the present study, a comparison of this pain alleviating method was made before the LA administration. Transcutaneous electrical nerve stimulation have been shown to significantly reduce pain and discomfort. Transcutaneous electrical nerve stimulation works on the principle of “gate control theory” which states that there is a gateway in the spinal cord’s dorsal horn which regulates the transmission of pain messages that are then sent to (ascending pathways) and (descending pathways) higher brain levels for central processing, thereby decreasing perception of pain. Some postulated mechanisms of TENS-mediated pain relief include stimulating endorphin release in the spinal cord.5,6 Transcutaneous electrical nerve stimulation stimulates large-diameter nerve fibers with a lower threshold to electrical activity than smaller diameter fibers.7 Nociceptive fibers (A-delta and C-fibers) have a higher threshold of activation than mechanoreceptive fibers (A-beta fibers). Melzack and Wall proposed that it would be possible to selectively stimulate mechanoreceptive fibers by titrating the amplitude of electrical currents delivered across the mucosal surface.8

Figs 6A and B: EMLA gel application in group III

Figs 7A and B: Vibrator device placement in group IV

Fig. 8: Wong–Bakers faces rating scale

Table 1: FLACC scale
CategoryScoring
012
FaceNo particular expression or smileOccasional grimace or frown, withdrawn, disinterestedFrequent to constant quivering chin, clenched jaw
LegsNormal position or relaxedUneasy, restless, tenseKicking, or legs drawn up
ActivityLying quietly, normal position, moves easilySquirming, shifting back and forth, tenseArched, rigid or jerking
CryNo cry (awake or asleep)Moans or whimpers; occasional complaintCrying steadily, screams or sobs, frequent complains
ConsolabilityContent, relaxedReassured by occasional touching, hugging or being talked to, distractibleDifficult to console or comfort

Fig. 9: Self-evaluation by a child using Wong–Baker faces rating scale

Fig. 10: Comparison of mean Wong–Baker faces pain rating scale scores for pain between different study groups

The advantages of TENS are:

Quarnstorm Fred conducted a study using TENS for pediatric procedures where no pain was felt during extraction.9 A study conducted by Bishop TS using TENS on pediatric patients where restorative procedures were carried and reported success of 92.8%.10 Segura et al. also reported minimum pain with TENS in the 7 to 12 years of age group during restorative procedures.11 Clark et al. also reported successful endodontic procedures with TENS.12

The only limitation of this study was that the pen electrodes were bulky, and handling of the TENS unit requires the need of the second operator. To overcome this, pen electrodes were modified to be used for a single operator (Fig. 12).

Table 2: Comparison of mean WBFPRS scores for pain between different study groups
NMeanStd. deviationStd. error95% confidence interval for mean
MinimumMaximum
Lower boundUpper bound
1152.402.2930.5921.133.6706
2156.402.7460.7094.887.92210
3154.132.3260.6012.855.4208
4153.201.9710.5092.114.2906
Total604.032.7430.3453.324.74010

Fig. 11: Comparison of mean FLACC scores for pain between different study groups

Fig. 12: Modification of pen electrodes

Table 3: Comparison of mean FLACC score for pain between different study groups
NMeanStd. deviationStd. error95% confidence interval for mean
MinimumMaximum
Lower boundUpper bound
1151.471.4070.3630.692.2505
2155.403.1800.8213.647.16210
3152.271.5340.3961.423.1204
4151.801.4240.3681.012.5905
Total602.732.5300.3272.083.39010

Its use in children with epileptic disorders, central nervous system disorders such as trigeminal neuralgia, congenital heart disease, and children with pacemakers is contraindicated.

The use of vibrating devices is another technique in reducing the pain of LA injections. It works on the principle of the gate control theory of pain and stimulates A-beta nerve fiber input from a vibration stimulus which would inhibit smaller fiber A-delta and C fiber (nociceptive) input from a transmucosal needle injection.4 It was suggested that vibrating devices generate a distractive environment that causes the brain cells to relay the vibrations, thus giving room for anesthesia delivery. A study conducted by Blair founds the same results using VibraJect in children.13 However, a massager-like device using extraoral vibrating stimuli is the first of its kind used in the present study for reducing pain and discomfort in children during LA administration.

Advantages

  • Extraoral vibration makes child-friendly device becomes more comfortable for the child and renders effective dental care.
  • From the aspect of child pain management, this device contributes both physiologically and psychologically useful tools.

The only disadvantage of the vibrator is the first quiver after placement at the desired location.

Topical anesthetics reversibly block nerve conduction near their site of administration by targeting free nerve endings in the mucosa which causes transient loss of sensation in a particular area. Nerve impulse conduction is stopped by lowering nerve cell membrane permeability to sodium ions, possibly by competing with calcium-binding sites that control the permeability of sodium. This change in permeability lowers depolarization and raises the excitability threshold until the ability to produce an action potential is lost.14

Eutectic mixture of lignocaine and prilocaine is a commercial anesthetic agent that has got acceptance by dental clinicians. The EMLA cream proves to be effective in reducing pain during ultrasonic scaling, rubber-dam clamp placement, and subgingival tooth preparation.15 Disadvantage of EMLA cream is it gives an unusual sensation of taste.

2% lignocaine has a limited capacity of penetrating deep into the tissue. Though the discomfort due to surface penetration is minimized, at greater depths of penetration, they are ineffective.

There are various faces rating scales for young children were introduced. The Wong–Baker faces pain rating scale is simple, easy to understand, and has shown a positive correlation. In several studies, it has been used for assessing pain in children and adults. FLACC scale is a good and reliable scale as trained observer notices the behavioral expression of child and assess the child pain reaction for pain assessment. Hence, in the present study, Wong–Baker faces pain rating scale and FLACC scale were used.

CONCLUSION

It can be concluded that TENS proved to be more effective, comfortable, and it significantly reduces pain during LA administrations. Transcutaneous electrical nerve stimulation prove to be a safe, reliable, and practical technique to be used in pediatric dentistry.

REFERENCES

1. Dhindsa A, Pandit IK, Srivastava N, et al. Comparative evaluation of the effectiveness of electronic dental anesthesia with 2% lignocaine in various minor pediatric dental procedures: a clinical study. Contemp Clin Dentis 2011;2(1):27.

2. Choudhari SR, Solanki PJ, Vispute GK, et al. Efficacy of transcutaneous electronic nerve stimulation in alleviating pain during inferior alveolar nerve block injections in pediatric dentistry. Int J Pedodon Rehabilitat 2017;2(2):69.

3. Lee HS. Recent advances in topical anesthesia. J Dent Anesthe Pain Med 2016;16(4):237–244.

4. Nanitsos E, Vartuli R, Forte A, et al. The effect of vibration on pain during local anaesthesia injections. Australian Dent J 2009;54(2):94–100.

5. Sato KL, Sanada LS, Da Silva MD, et al. Transcutaneous electrical nerve stimulation, acupuncture, and spinal cord stimulation on neuropathic, inflammatory and, non-inflammatory pain in rat models. Korean J Pain 2020;33(2):121.

6. Kasat V, Gupta A, Ladda R, et al. Transcutaneous electric nerve stimulation (TENS) in a dentistry-a review. J Clin Experim Dentis 2014;6(5):e562.

7. Johnson M. Transcutaneous electrical nerve stimulation: mechanisms, clinical application and evidence. Rev Pain 2007;1(1):7–11.

8. Tashani O, Johnson MI. Transcutaneous electrical nerve stimulation (TENS) a possible aid for pain relief in developing countries? Libyan J Med 2008;4(2):62–65.

9. Quarnstrom F. Electronic dental anesthesia. Anesthe Prog 1992;39(4-5):162.

10. Bishop TS. High frequency neural modulation in dentistry. J Am Dent Assoc (1939) 1986;112(2):176.

11. Segura A, Kanellis M, Donly KJ. Extra oral electronic dental anesthesia for moderate procedures in pediatric dentistry. J Dent 1995;74:27.

12. Clark SM, Silverstone LM, Lindermath J, et al. An evaluation of the clinical analgesia/anesthesia efficacy on acute pain using the high frequency neural modulator in various dental setting. Oral Surg Oral Med Oral Pathol 1989;63:501–505.

13. Shilpapriya M, Jayanthi M, Reddy VN, et al. Effectiveness of new vibration delivery system on pain associated with injection of local anesthesia in children. J Indian Soc Pedodo Prevent Dentis 2015;33(3):173.

14. Kumar M, Chawla R, Goyal M. Topical anesthesia. J Anaesthe Clin Pharmacol 2015;31(4):450.

15. Lim S, Julliard K. Evaluating the efficacy of EMLA topical anesthetic in sealant placement with rubber dam. Pediat Dentis 2004;26(6):497–500.

________________________
© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.